FDA grants breakthrough device designation for implantable insulin pump

Healio·Feb 23

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The FDA has granted breakthrough device designation for an implantable insulin pump. The designation was given to Portal Diabetes for its insulin pump. However, it is unclear if this is the only device to recently receive such a designation, as other devices have also been mentioned in relation to FDA breakthrough designations.

Full coverage

FDA Grants Breakthrough Designation to Sonorous Neurovascular for Cerebral Venous Stent

Medical Product Outsourcing·Mar 31

Portal Diabetes Gets FDA Breakthrough for Pump, Starts Insulin Study

PR Newswire·Feb 17

FDA Grants Breakthrough Designation for Heart Failure Device

Medical Device and Diagnostic industry·Nov 29

Insulet Begins Voluntary Medical Device Correction for Certain Omnipod 5 Pods in the U.S.

Medical Product Outsourcing·Mar 13

FDA Clears Cala’s Wearable Device for Essential Tremor and Parkinson’s Disease

Medical Product Outsourcing·Apr 15

View original report at Healio ↗

Fetching the latest headlines…